CareSwift

Executive Summary

CareSwift is a YC-backed (S25) pre-seed startup building an AI documentation layer for EMS ePCR workflows — a real problem in a real but niche market ($150M–$250M U.S. SAM for ePCR documentation software). The founding team has authentic domain credibility: the CEO is a practicing EMT who built the prototype to solve his own pain point, but all three founders are college students with no prior B2B SaaS, healthcare IT, or enterprise sales experience. None of the core traction claims — 80% documentation time reduction, 100% compliance, 2,000+ clinicians, 7 states — can be independently verified; they are self-reported marketing assertions unsupported by any third-party data. The single biggest risk is regulatory: CareSwift's AI validates medical necessity in real-time and targets billing optimization, putting it squarely in the crosshairs of FDA SaMD classification, HIPAA business associate obligations, and False Claims Act scrutiny — a compliance burden that $500K in pre-seed capital is almost certainly insufficient to address.